Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CB2 receptor agonist proves useful for the treatment of erectile dysfunction

Sep. 3, 2012

Takeda presents novel inhibitors of ACC2

Sep. 3, 2012

Topical cream improves female sexual arousal disorder in phase III trial

Aug. 31, 2012

Noven files NDA for therapy for menopausal vasomotor symptoms

Aug. 30, 2012

FDA provides recommendations for Proellex trial

Aug. 28, 2012

Tenelia set for launch in Japan

Aug. 28, 2012

Recruitment begins for phase III trial in children with precocious puberty

Aug. 28, 2012

Growject approved for fourth indication in Japan

Aug. 24, 2012

Sato Pharmaceutical designs new urate anion exchanger inhibitors

Aug. 24, 2012

Investigators extract new HMG-CoA reductase inhibitors from yeast

Aug. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...